Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elodie de Bock"'
Autor:
Robert P. Lavan, Muna Tahir, Christina O’Donnell, Alex Bellenger, Elodie de Bock, Patricia Koochaki
Publikováno v:
Animals, Vol 13, Iss 20, p 3255 (2023)
The use of valid questionnaires to assess dogs’ health-related quality of life (HRQoL) in veterinary practice can improve canine health outcomes and communications between veterinarians and caretakers of dogs. The Canine HRQoL Questionnaire (Canine
Externí odkaz:
https://doaj.org/article/7dd7b37ebc944cfe9afb4a7a5ad0cf1a
Autor:
Jeffrey R. Curtis, Jan Michael Nebesky, Elodie de Bock, Christine de la Loge, Benoit Arnould, Robert Davey, Jenny Devenport, Attila Pethö-Schramm
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-12 (2021)
Abstract Objective Despite the development of new biologic therapies, methotrexate (MTX) remains the preferred initial disease-modifying anti-rheumatic drug to treat rheumatoid arthritis (RA). Adherence to disease-modifying anti-rheumatic drugs is su
Externí odkaz:
https://doaj.org/article/481b0d94b6924eeeaa605a60e5432c79
Autor:
Elodie de Bock, Kevin Dolgin, Léa Kombargi, Benoit Arnould, Tanguy Vilcot, Guillaume Hubert, Marie-Eve Laporte, Lydiane Nabec, Gérard Reach
Publikováno v:
Patient Preference and Adherence. 16:1213-1231
Elodie de Bock,1 Kevin Dolgin,2 Léa Kombargi,2 Benoit Arnould,1 Tanguy Vilcot,1 Guillaume Hubert,2 Marie-Eve Laporte,3 Lydiane Nabec,4 Gérard Reach5 1Patient Centred Outcomes, ICON plc, Lyon, France; 2Observia, Paris, France; 3IAE Paris - Sorbonne
Autor:
Attila Pethö-Schramm, Jan Michael Nebesky, Jenny Devenport, Benoit Arnould, Elodie de Bock, Jeffrey R. Curtis, Christine de la Loge, Robert Davey
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-12 (2021)
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes
Objective Despite the development of new biologic therapies, methotrexate (MTX) remains the preferred initial disease-modifying anti-rheumatic drug to treat rheumatoid arthritis (RA). Adherence to disease-modifying anti-rheumatic drugs is suspected t
Publikováno v:
Advances in Therapy
Introduction BAY 94-9027 is a newly developed extended half-life product to treat haemophilia, allowing for fewer injections than with standard products. This post hoc analysis aimed to compare physicians’ and patients’ opinions on BAY 94-9027 pr
Publikováno v:
Current medical research and opinion. 38(2)
The SPUR (Social, Psychological, Usage, and Rational) Adherence Profiling Tool is a recently developed adaptive instrument for measuring key patient-level risk factors for adherence problems. This study describes the SPUR questionnaire's psychometric
Autor:
Philippe Devillier, Gaëlle Bruneteau, Capucine Morélot-Panzini, Christophe Pignier, Thierry Perez, Bernard Aguilaniu, Thomas Similowski, Elodie de Bock, Kamila Sedkaoui, Benoit Arnould
Publikováno v:
Respiratory Medicine
Respiratory Medicine, 2018, 145, pp.1-7. ⟨10.1016/j.rmed.2018.10.010⟩
Respiratory Medicine, 2018, 145, pp.1-7. ⟨10.1016/j.rmed.2018.10.010⟩
International audience; Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder leading to chronic respiratory failure. Few studies have investigated ALS-related dyspnoea, and none have characterised the emotional distress it